Delivery Order SPE2DR25D1053-SPE2DR26FT792
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Envarsus XR 4 mg tablets (100-count units) valued at $3,608.26. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is scheduled for completion by December 4, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Envarsus XR 4 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order valued at $5,412.39, with performance to be completed by December 5, 2025, at the contractor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,711.95 to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 4 mg on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed price, non-set-aside contract represents a pharmaceutical supply delivery executed under a competitively awarded vehicle. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Envarsus XR 1 mg tablets in a quantity of 100s, with a ceiling value of $1,718.48 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract that will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 15, 2025. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Envarsus XR 1 mg tablets (100-count supply) on November 14, 2025, with a firm fixed price ceiling value of $1,358.25 and an ultimate completion date of December 8, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Envarsus XR 0.75 mg tablets (100 count) with a ceiling value of $2,037.96 and a firm fixed price structure. This delivery order is non-competitive and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Envarsus XR 0.75 mg tablets (30-count) with a contract ceiling value of $1,169.76. This is a firm fixed-price delivery order without a set-aside designation, issued under competitive procurement procedures. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of October 16, 2025. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,811.00 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Envarsus XR 1 mg tablets (100-count package). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies an ultimate completion date of December 5, 2025, and the pharmaceutical product will be delivered to AmerisourceBergen's distribution facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Envarsus XR 4 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $4,712.76. The contract is scheduled for completion by October 7, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order represents a non-set-aside, competitively awarded procurement and is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,423.90 to AmerisourceBergen Drug Corp for the supply of Envarsus XR 4 mg tablets (100-count bottles) on August 25, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The contract is issued as a child order under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT792Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Envarsus XR 4 mg tablets (100-count units) with a ceiling value of $3,608.26. This is a firm fixed-price delivery order with no set-aside designation, placing performance in Conshohocken, Pennsylvania, and scheduled for completion by December 3, 2025. The award represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's DLA IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. This delivery order for Envarsus XR—a tacrolimus formulation used in transplant immunosuppression—exemplifies the routine pharmaceutical fulfillment activities under this large-scale prime vendor contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 11/10/25 |